Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Medline has begun piloting its AI-powered supply chain platform, Mpower, with 10 health systems in the U.S. Built in collaboration with Microsoft, Mpower is a cloud-based “digital control tower.”. The platform uses real-time data and predictive analytics to help providers…
Fresenius Kabi has issued a software correction for its Ivenix large-volume pump after identifying anomalies that could cause therapy interruptions or delays. The update affects Ivenix pump software version 5.10.1 and earlier. On Feb. 25, the FDA classified the action…
Ochsner Health in New Orleans has named Mark French chief supply chain officer. Mr. French most recently served as Ochsner’s COO of supply chain and support services from December 2022 to February 2026. He previously held the role of vice…
The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from increased reports of deployment and expansion issues during stent placement. As…
Vice President JD Vance and CMS Administrator Mehmet Oz, MD, announced a series of actions affecting Medicare and Medicaid, including a $259.5 million deferral of federal Medicaid funding in Minnesota and a six-month moratorium on new Medicare enrollment for certain…
The FDA has issued an early alert regarding certain Abiomed Impella system components after the company recommended removing specific products from use because of an increased risk of purge leaks. In a Feb. 18 letter to customers, Abiomed said it…
Hospital supply chain leaders are rethinking how reliability, cost control and clinical alignment can coexist as traditional strategies fall short. A Feb. 24 report from ECRI argues that amid rising pressure, decisions must be built on structured, decision-ready evidence—not instinct…
The FDA has approved Allurion Technologies’ gastric balloon system, a swallowable weight loss device that does not require surgery, endoscopy or anesthesia. The device is indicated for adults with a body mass index of 30 to 40 kg/m², potentially expanding…
AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, with the facilities expected to be fully operational in 2029, the…
The FDA’s Breakthrough Devices Program is designed to accelerate development and review of devices that offer meaningful advances in care for serious or life-threatening conditions. With more than 1,200 devices designated since 2015, the program has become a central pathway…